Increased prevalence of platelet glycoprotein IIb/IIIa PLA2 allele in ischaemic stroke associated with large vessel pathology

Thrombosis Research

Volumn 109, Issue 5-6, 2003, Pages 265-269

  Szolnoki, Zoltán ^a   Somogyvári, Ferenc ^b   Kondacs, András ^a   Szabó, Mihály ^a   Bene, Judit ^c   Havasi, Viktória ^c   Komlósi, Katalin ^c   Melegh, Béla ^a  

^a Dept of Neurol and Neurophysiology ^*  (Hungary)

^b Pandy Kalman County Hospital   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Genetic risk factors; MRI based classification; PLA2 polymorphism; Stroke

Indexed keywords

FIBRINOGEN RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 0038006807     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(03)00258-5     Document Type: Article

References (28)

1. Durante-Mangoni E., Davies G.J., Ahmed N., Ruggiero G., Tuddenham E.G. Coronary thrombosis and the platelet glycoprotein IIIA gene PLA2 polymorphism. Thromb. Haemost. 80:1998;218-219.
2. Cadroy Y., Sakariassen K., Grandjean H., Thalamas C., Boneu B., Sie P. The effect of platelet PlA polymorphism on experimental thrombus formation in man depends on blood flow and thrombogenic substrate. Thromb. Haemost. 85(6):2001;1097-1103.
3. Kastrati A., Schömig A., Seyfarth M., Koch W., Elezi S., Bottiger C.et al. PLA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. Circulation. 99:1999;1005-1010.
4. Hooper W.C., Lally C., Austin H., Benson J., Dilley A., Wenger N.K.et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans. Chest. 116:1999;880-886.
5. Wiess E.J., Bray P.F., Tayback M., Schulman S.P., Kickler T.S., Becker L.C.et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 334:1996;1126-1128.
6. Mikkelsson J., Perola M., Penttila A., Goldschmidt-Clermont P.J., Karhunen P.J. The GPIIIa (beta3 integrin) PlA polymorphism in the early development of coronary atherosclerosis. Atherosclerosis. 154(3):2001;721-727.
7. Mikkelsson J., Perola M., Laippala P., Penttila A., Karhunen P.J. Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death. J. Am. Coll. Cardiol. 36(4):2000;1317-1323.
8. Carter A.M., Catto A.J., Bamford J.M., Grant P.J. Platelet GP IIIa PIA and GP Ib variable number tandem repeat polymorphisms and markers of platelet activation in acute stroke. Arterioscler. Thromb. Vasc. Biol. 18:1998;1124-1131.
9. Wagner K.R., Giles W.H., Johnson C.J., Ou C.Y., Bray P.F., Goldschmidt-Clermont P.J.et al. Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: the stroke prevention in young women study. Stroke. 29:1998;581-585.
10. Pongracz E., Tordai A., Csornai M., Nagy Z. Platelet glycoprotein IIb/III (LeuPro 33) polymorphism in stroke patients. Orv. Hetil. 142:2001;781-785.
11. Carlsson L.E., Greinacher A., Spitzer C., Walther R., Kessler C. Polymorphism of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke. 28:1997;1392-1395.
12. Ridker P.M., Hennekens C.H., Schmitz C., Stampfer M.J., Lindpaintner K. PlA1/A2 polymorphysm of platelet glycoprotein IIIa and risk of myocardial infarction, stroke, and venous thrombosis. Lancet. 349:1997;385-388.
13. Reuner K.H., Elgas M., Kaps M., Ruf A., Patscheke H. The human platelet antigen HPA-1a/1b (PlA1/PlA2) polymorphism and cerebral ischaemia. Thromb. Haemost. 78:1997;964-965.
14. Corral J., Gonzalez-Conejero R., Rivera J., Iniesta J.A., Lozano M.L.et al. HPA-1 genotype in arterial thrombosis - role of HPA-1b polymorphism in platelet function. Blood Coagul. Fibrinolysis. 8:1997;284-290.
15. Kekomaki S., Hamalainen L., Kauppinen-Makelin R., Palomaki H., Kaste M., Kontula K. Genetic polymorphism of platelet glycoprotein IIIa in patients with acute myocardial infarction and acute ischaemic stroke. J. Cardiovasc. Risk. 6:1999;13-17.
16. Diabetes mellitus. Report of a WHO Study Group. World Health Organ. Tech. Rep. Ser. 727:1985;1-113.
17. Jin Y., Dietz H.C., Nurden A., Bray P.F. Single-strand conformation polymorphism analysis is a rapid and effective method for the identification of mutations and polymorphisms in the gene for glycoprotein IIIa. Blood. 82:1993;2281-2288.
18. Johnson C.J., Kittner S.J., McCarter R.J., Sloan M.A., Stern B.J., Buchholz D.et al. Interrater reliability of an etiologic classification of ischemic stroke. Stroke. 26:1995;46-51.
19. Bamford J. Clinical examination in diagnosis and subclassification of stroke. Lancet. 339:1992;400-402.
20. Adams H.P. Jr., Bendixen B.H., Kappelle L.J., Biller J., Love B.B., Gordon D.L.et al. Classification of subtype of acute ischaemic stroke. Definitions for use in a multicenter clinical trial. Stroke. 24:1993;35-41.
21. Masuda J., Nabika T., Notsu Y. Silent stroke: pathogenesis, genetic factors and clinical implications as a risk factor. Curr. Opin. Neurol. 14:2001;77-82.
22. Fisher C.M. Lacunes, small, deep cerebral infarcts. Neurology. 15:1965;774-784.
23. Kobayashi S., Okada K., Yamashita K. Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke. 22:1991;1379-1383.
24. Price T.R., Manolio T.A., Kronmal R.A., Kittner S.J., Yue N.C., Robbins J.et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke. 28:1997;1158-1164.
25. Shinkawa A., Ueda K., Kiyohara Y., Kato I., Sueishi K., Tsuneyoshi M.et al. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama study. Stroke. 26:1995;380-385.
26. Vijayan K.V., Goldschmidt-Clermont P.J., Roos C., Bray P.F. The Pl(A2) polymorphism of integrin beta(3) enhances outside-in signaling and adhesive functions. J. Clin. Invest. 105:2000;793-802.
27. Goodall A.H., Curzen N., Panesar M., Hurd C., Knight C.J., Ouwehand W.H.et al. Increased binding of fibrinogen to glycoprotein IIIa-proline33 (HPA-1b, PlA2, Zwb) positive platelets in patients with cardiovascular disease. Eur. Heart J. 20:1999;742-747.
28. Corral J., Gonzalez-Conejero R., Rivera J., Iniesta J.A., Lozano M.L., Vicente V. HPA-1 genotype in arterial thrombosis - role of HPA-1b polymorphism in platelet function. Blood Coagul. Fibrinolysis. 8:1997;284-290.